Figure 1. Sequence Alignment of Mouse Carnitine Acetyltransferase (CRAT) and Human Liver-and Muscle-Type Carnitine Palmitoyltransferase I (L-CPT-I and M-CPT-I).
The secondary structure elements in the CRAT structure are labeled (S.S.). Residues shown in green are in the core of the protein, with less than 25% exposed surface area. Residues in the carnitine (C), CoA (A), and fatty acid (F) binding pockets are also indicated. The residue numbers are for CRAT. An additional 140 residues at the N terminus of L-CPT-I and M-CPT-I are not shown. A dash represents a residue that is identical to that in CRAT, while a dot represents a deletion.
cluding the initiator Met). A total of 40 Se sites were
The molecules in the asymmetric unit of these crystals have essentially the same conformation, with rms dislocated based on the anomalous differences, and our structural analysis showed that the Met residue near the tance of 0.34 Å for 587 equivalent C␣ atoms. The contacts among the non-crystallographically related and N terminus of each protein molecule is disordered. This Met residue is present only in the recombinant protein, the crystallographically related dimers in these crystals are generally weak and hydrophilic in nature. The protein introduced as a part of the His-tag by the expression vector. The N-terminal His-tag is disordered in the migrates as monomers on gel filtration columns (data not shown). The structural observations are consistent crystal.
To determine the binding mode of the substrate carniwith biochemical data suggesting that the protein is monomeric in solution (Ramsay et al., 2001 ). tine or CoA, we produced crystals of mouse CRAT in the presence of these compounds. The subsequent structural analysis at 1.9 Å resolution defined the binding Overall Structure of CRAT The crystal structure of the free enzyme of mouse CRAT mode of carnitine in the active site, but showed the binding of oxidized CoA to the "wrong" region of the has been determined at 1.8 Å resolution. The current atomic model contains residues 30-625 for each of the active site. In these CoA crystals, the thiol of CoA was oxidized to a sulfonic acid, even in the presence of two molecules in the asymmetric unit, which essentially corresponds to the full-length, mature form of this en-10 mM DTT in the crystallization solution. The sulfonic group of oxidized CoA is bound in the pocket that recogzyme. All the residues except Ile116 are located in favored regions of the Ramachandran plot. Ile116 is the nizes the carboxylate group of carnitine, supporting the preference for a negatively charged group in that pocket.
second residue in a type II reverse turn, and its main chain conformation is clearly defined by the electron The ADP portion on the other end of the CoA molecule is disordered.
density. The crystallographic information is summarized in Table 1 . The binding mode of CoA was determined instead from an X-ray diffraction data set on a free enzyme The structure of CRAT contains 16 ␤ strands (␤1-␤16) and 20 ␣ helices (␣1-␣20) and can be divided into two crystal soaked with acetyl-CoA. The crystal suffered serious damage during the soaking process, and the domains (Figure 2A ). The C domain contains a sixstranded mixed ␤ sheet, together with eleven ␣ helices. quality of the diffraction data set is rather poor (Table  1) . Consequently, the R factor for the atomic model is Residues in this domain include the C-terminal 1/3 of the protein (residues 407-626) as well as residues 30-95 high (Table 1) . Nonetheless, the binding mode of CoA is clearly defined by the electron density map. at the N terminus, which contribute four ␣ helices to this 
|I hi . The numbers in parentheses are for the highest resolution shell.
2 The number for the free enzyme includes both Friedel pairs.
domain and interact with a segment between ␣17 and the long connection between the N and the C domains ( Figure 2A ). ␤13 ( Figure 2B ). One face of the ␤ sheet in this domain is covered by the ␣ helices, whereas part of the other The N domain contains an eight-stranded mixed ␤ sheet, which is covered on both sides by eight ␣ helices face of this sheet contacts the N domain of the structure (residues 96-385). Helix ␣13, residues 386-487, forms ( Figure 2C ). This eight-stranded ␤ sheet is formed by flanking the central six-stranded sheet with one extra ␤ acid residues each, larger than the sizes of CAT and E2pCD (about 220 residues). As a result, the two dostrand on each of its edges ( Figure 2C ). Interestingly, one of these extra ␤ strands actually comes from the C mains in CRAT have significant insertions in several of the surface loops as compared to CAT or E2pCD (Figdomain . Part of the ␤13-␤15 crossover connection in the C domain forms a ␤ strand (␤14) (Figure 2B ), and ures 2B-2D). These insertions form additional interactions within the domains, for example those between this strand is hydrogen-bonded to ␤1 in an anti-parallel fashion in the N domain ( Figure 2C ). The N domain also the ␣18-␣19 insertion and helices ␣2-␣4 in the C domain ( Figure 2B ). In the N domain, the ␣8-␣10 and ␣11 insercontains a pair of ␤ strands (␤2 and ␤3) on the surface, helping enclose one end of the ␤ sheet.
tions cover the face of the ␤ sheet ( Figure 2C ) that would be shielded from solvent by the third monomer in the Surprisingly, the N and C domains share very similar polypeptide backbone folds ( Figures 2B and 2C mechanism, between CRAT and these other enzymes atoms in CAT can be superimposed with the equivalent (see below). atoms in the C domain of CRAT, and the rms distance of these atoms is 3.7 Å . The amino acid sequence identity among these structurally equivalent residues is however The Carnitine Binding Site The crystal structure of CRAT in complex with the subonly 9%. Similar observations are made when the CAT structure is aligned with the N domain of CRAT or when strate carnitine has been determined at 1.9 Å resolution ( Table 1 ). The binding mode of carnitine is clearly defined the structure of E2pCD is used for comparison.
Most remarkably, the structural conservation between by the crystallographic analysis ( Figure 3A) . We have also collected X-ray diffraction data on crystals of CRAT CRAT and CAT or E2pCD extends beyond the similarity in their backbone folds. The organization of the two grown in the presence acetylcarnitine, the product of the reaction. The subsequent crystallographic analysis, domains of CRAT is similar to that of two monomers in the trimers of CAT and E2pCD ( Figure 2E ). The rotational at 1.9 Å resolution, showed however the presence of only carnitine in the active site (data not shown). This relationship between the N and C domains of CRAT is 118Њ, close to a 3-fold rotation. Both CAT and E2pCD suggests that the acetylcarnitine has been hydrolyzed to carnitine during the crystallization process, and this function as trimers, and the active site of the enzymes is located at the interface between a pair of monomers hydrolysis may possibly be catalyzed by the enzyme itself. in the trimer ( Figure 2E) The carnitine binding site is formed by the ␤ sheet (strands ␤11-␤14) in the C domain and residues in ␣5-␤1 the N and C domains of CRAT contain about 300 amino The carboxylate group of carnitine has electrostatic 1). Our structural observations on the binding interactions of carnitine are supported by a large body of experinteractions with the side chain guanidinium group of Arg518 (from helix ␣18), with a distance of about 4 Å , imental data on mutants of these enzymes, as well as by the natural variations in the sequences of these enzymes as well as a network of hydrogen-bonding interactions ( Figures 3B and 3D) Figure  3D ) and are conserved among all carnitine acyltransferbonded to the side chain hydroxyl of Thr465 (␤12) and a water molecule. The tetrahedral coordination of this ases (Figure 1) . However, these two residues are not conserved in the homologous choline acetyltransferwater is completed by three ligands from the enzyme, the N⑀1 atom of Trp102 (␣5), the O atom of Tyr107 (␣5), ases, because the choline substrate lacks a carboxylate group at this position (Cronin, 1997a). Moreover, the and the O⑀2 atom of Glu347 (␤8-␣12 loop), which also shield it from the solvent ( Figure 3B) .
Arg→Asn mutation in bovine COT led to a 1650-fold increase in the K m for carnitine, while having little effects The trimethylammonium group of carnitine is situated Figure 3D ). Outside the active site, conformational differences are 1997a). Our structure shows an indirect, electrostatic interaction between this residue and the carboxylate observed for several regions on the surface of the structure. In addition, there are small rigid body movements group (Figure 3D ), rather than a direct binding via hydrogen-bonding interactions.
of the domains relative to each other. However, these changes are more likely due to flexibility in the enzyme In the binding site for the trimethylammonium group, Ser552 is the first residue of the strictly conserved STS or differences in crystal packing, and they have only minor impact on the active site region. motif among these acyltransferases (Figure 1) . Mutation of this Ser residue to Ala in bovine COT produced a 17-fold increase in the K m for carnitine, but only a 2-fold
The CoA Binding Site The crystal structure of CRAT in complex with the subdecrease in the k cat of the enzyme (Cronin, 1997b), consistent with our structural observations ( Figure 3B ). Instrate CoA has been determined at 2.3 Å resolution (Table 1) . To obtain this structure, X-ray diffraction data terestingly, mutation of the Thr residue in this motif to Ala produced a 90-fold increase in the K m for carnitine, were collected on a crystal of the free enzyme of CRAT that was soaked overnight with 1.5 mM acetyl-CoA. The even though the side chain of this residue is pointed away from the active site. Detailed structural analysis crystal suffered serious damage during the soak, giving rise to higher R factors for the diffraction data and the showed that the side chain hydroxyl of the Thr residue is hydrogen-bonded to the main chain carbonyl oxygen atomic model (Table 1) . Nonetheless, the current data set is of sufficient quality to clearly define the binding of Tyr452 in strand ␤11 (Figure 3B) , and the mutation may have disrupted the conformation of the enzyme in mode of the substrate ( Figure 4A ). It also indicates that the compound bound in the active site is actually CoA this area.
CRAT has a preformed binding site for the substrate ( Figure 4A ). This suggests that acetyl-CoA has been hydrolyzed to CoA during the overnight soaking procarnitine. The only significant conformational difference in the active site between the free enzyme and the carnicess. Therefore, it appears that CRAT may be able to catalyze the hydrolysis of both acetylcarnitine and acetine complex is in the side chain of Ser454, which adopts a different rotamer to have better hydrogen-bonding tyl-CoA. We have also obtained cocrystals of the en- tion on these enzymes provides the foundation for unmutation on the catalysis by COT also supports the derstanding their catalytic mechanism and for strucfunctional role of the carnitine substrate itself in stabiliztural-based design and optimization of their inhibitors. ing the transition state of this reaction.
Experimental Procedures

Disease-Causing Mutations Protein Expression and Purification
The crystal structure provides a molecular basis for unResidues 30-626 of mouse carnitine acetyltransferase (CRAT) was subcloned into the pET28a vector (Novagen) and overexpressed in derstanding the effects of most of the natural and engi-
